Although interventions such as syringe service programs have attempted to address the need for sterilesyringes to prevent blood borne infections (BBI) among people who inject drugs (PWID) the programs areoften fragmented and therefore difficult to evaluate in terms of a product with potential for widespreaddissemination and implementation in a sustainable manner. Further these types of prevention efforts do notexist universally across the U.S. especially in the Southwestern region among largely minority populations.Access to Syringes at Pharmacies (ASAP) is a refinement of an evidence-based pharmacy intervention toincrease pharmacy-based sales of syringes to PWID in order to reduce BBI among them. The refinementintegrates a motivational enhancement to reduce staff ambivalence about syringe sales to PWID samplingimprovements to assure that project pharmacies are likely serving PWID and refinements to the interventiontraining content and delivery in three selected Arizona project counties of Mohave Maricopa and Pima. Ourdevelopment and refinement of ASAP relies on: 1) interviews with pharmacy staff of 6 pharmacies (2 for eachcounty) that will assess feasibility acceptance and likely adoption of the initial draft of the ASAP interventionand 2) interviews and surveys among pharmacy staff of 3 pharmacies (1 from each county). ASAPsadaptations and refinements will be guided by a highly iterative process between investigators and acommunity advisory board (CAB). Further the Consolidated Framework for Implementation Research (CFIR)will guide feasibility assessment with a focus on selected CFIR elements across the domains of interventioncharacteristics outer and inner setting characteristics of individuals and process. The project will occur in twophases. The Year 1 formative phase will involve: 1) in-depth interviews with staff of 6 pharmacies to clarifyintervention components training and feasibility. Findings will inform the Year 2 iterative ASAP developmentand refinement phase between investigators and the CAB; including extensive feedback from pharmacy staffof 3 pharmacies following an ASAP beta test. Specific Aims are: Aim 1: To conduct the formative research among pharmacy staff required to develop and beta testthe ASAP intervention materials (e.g. training manual manual of operations evaluation protocols). Aim 2: To determine the feasibility of the ASAP intervention relative to impact on pharmacy syringe-related sales and pharmacy interactions with PWID at time of syringe buy request.